Tickerplace logo

Tickerplace

Takeda Pharmaceutical Company Limited logo

TAKTakeda Pharmaceutical Company Limited

TAK Stock Price, Valuation & Chart | Takeda Pharmaceutical Company Limited

Compare
$19.670+0.22 (+1.13%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
OverviewFinancialsDividendsRatios

TAK Historical price chart

TAK Key Stats

Market Capitalization62.18B
PE Ratio14.14
EPS1.39
Trading Volume2.72M
Today's High/Low19.7/19.57
Dividend Yield3.25
52 Week High/Low19.89/12.99
Shares Outstanding3.16B
TAK Financial Statement
TAK Analyst ratings
TAK Analysis & performance metrics

TAK Company profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States,…

TAK Management team

Management
Norimasa Takeda
Chief Accounting Officer & Corporate Controller
Iwaaki Taniguchi
Senior Vice President of Corporate Finance & Controlling Department
Haruhiko Hirate
Member of Management Board
Seigo Izumo
Chair of Management Board
Christophe WeberCEO
President, Chief Executive Officer & Representative Director
Gabriele Ricci
Chief Data & Technology Officer
Christopher David O'Reilly
Global Head of Investor Relations & Global Finance
Milano FurutaCFO
Chief Financial Officer & Director
Total 8 executives

TAK Frequently asked questions

What is Takeda Pharmaceutical Company Limited (TAK) Stock Price?

Current stock price of Takeda Pharmaceutical Company Limited (TAK) stock is $19.670. The stock price is +1.13% higher in the session. The intraday range can be seen from this page. Volume of Takeda Pharmaceutical Company Limited (TAK) stock is 2.72M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Takeda Pharmaceutical Company Limited (TAK) stock price going up or down today?

The stock price of Takeda Pharmaceutical Company Limited (TAK) can change with earnings, company news, and overall market sentiment. Takeda Pharmaceutical Company Limited operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Takeda Pharmaceutical Company Limited stock expensive at its current price?

Whether Takeda Pharmaceutical Company Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TAK on this page is 14.14. EPS on this page is 1.39. Compare those figures with peers and growth expectations before deciding if the current Takeda Pharmaceutical Company Limited price is justified.

How has the stock price of Takeda Pharmaceutical Company Limited (TAK) performed historically?

Historical performance for Takeda Pharmaceutical Company Limited (TAK) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TAK reacted to past earnings and market events.

Should I buy Takeda Pharmaceutical Company Limited (TAK) stock, at this price?

Buying Takeda Pharmaceutical Company Limited (TAK) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.